Double-blind evaluation of haloperidol for antiemetic activity.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000932:Antiemetics / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003475:Curettage; D003521:Cyclopropanes / Q000627:therapeutic use; D004106:Dilatation; D005260:Female; D006220:Haloperidol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008723:Methohexital / Q000627:therapeutic use; D008875:Middle Aged; D009325:Nausea / Q000517:prevention & control; D010919:Placebos; D011229:Preanesthetic Medication; D012119:Respiration / Q000187:drug effects; D013997:Time Factors; D014839:Vomiting / Q000517:prevention & control
D000932:Antiemetics; D003521:Cyclopropanes; D010919:Placebos; D008723:Methohexital; D006220:Haloperidol